You are here

Vtama

Dermavant CEO draws Botox comparison to instill Vtama confidence amid slow psoriasis uptake

Fierce Pharma

Tue, 11/28/23 - 11:29 pm

A year of two halves for US approvals

EP Vantage

Thu, 01/19/23 - 09:38 am

Bristol Myers Squibb

FDA approves Roivant drug, the first novel topical plaque psoriasis med in 25 years

MedCity News

Tue, 05/24/22 - 04:40 pm

plaque psoriasis